Work

International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation

Year: 2026
Type: article
Abstract: This Viewpoint explores whether savings from lower drug prices outweigh any downstream effects on manufacturer behavior, patient access, and future pharmaceutical innovation.
Language: English
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W7226003501
FWCI:
Cites: 7
Cited by:
Related to: 10